(Q43572273)

English

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Carlo Gambacorti-Passerini

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Barni R

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Marchesi E

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Verga M

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rossi F

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rossi F

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pioltelli P

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pogliani E

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Corneo GM

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

972-974

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02653.X

21 January 2018

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02653.X

21 January 2018

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02653.X

21 January 2018

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02653.X

21 January 2018

A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: a promising path for progress emerges

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02653.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02653.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43572273&oldid=2101205064"